Literature DB >> 26220007

[Provision of assistive devices in amyotrophic lateral sclerosis. Analysis of 3 years case management in an internet-based supply network].

A Funke1, T Grehl, J Großkreutz, C Münch, B Walter, D Kettemann, C Karnapp, N Gajewski, R Meyer, A Maier, K M Gruhn, T Prell, K Kollewe, S Abdulla, X Kobeleva, S Körner, S Petri, T Meyer.   

Abstract

BACKGROUND: The provision of assistive devices (PAD) is a key element of care in amyotrophic lateral sclerosis (ALS). Since 2011, assistive devices (AD) have been coordinated in an internet-supported care network at university-based ALS centers in Berlin, Bochum, Hannover and Jena. The digitization of PAD processes has facilitated the evaluation of real-life ALS care.
OBJECTIVES: Orthotics (OT), augmentative and alternative communication (AAC), supported treadmill (ST) and powered wheelchair (PW) were the PAD groups analyzed for delivery rates (proportion of delivered AD vs. medically indicated AD), rejection by patients and payers and latency of provision of care.
RESULTS: Between June 2011 and October 2014 a total of 1479 patients and 12,478 AD were coordinated, among which 3313 PAD were related to OT, AAC, ST or EM. The median delivery rate was 64.3 %. The mean rejection rate by patients was 9.8 % (OT 5.4 %, AAC 9.8 %, ST 10.2 % and PW 15.6 %). Marked differences were noted in the rejection rate by payers and in care provision latency: OT (16.2 %, 68 days, n = 734), AAC (30.4 %, 96 days, n = 392), ST (34.8 %, 113 days, n = 164) and PW (35.6 %, 129 days, n = 259). Analysis of rejection rates showed significant differences among insurers.
CONCLUSION: Only two thirds of the medically indicated AD reached the patients. Rejection rates by patients and payers and latency of provision of care were high. The PAD can substantially vary among health insurance companies. The establishment of consented criteria for PAD and their integration into treatment regimens and guidelines are crucial tasks for the future.

Entities:  

Mesh:

Year:  2015        PMID: 26220007     DOI: 10.1007/s00115-015-4398-2

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  12 in total

Review 1.  [Progressive muscle atrophy. A rarely diagnosed variant of amyotrophic lateral sclerosis].

Authors:  T Meyer; C Münch; F K H van Landeghem; N Borisow; J Dullinger; P Linke
Journal:  Nervenarzt       Date:  2007-12       Impact factor: 1.214

2.  [Optimizing provision of assistive technology. Expert opinion of the German Society for Rehabilitation, DVfR, on current issues in the provision of technical aids and assistive devices].

Authors: 
Journal:  Rehabilitation (Stuttg)       Date:  2007-06       Impact factor: 1.113

Review 3.  The role of augmentative communication devices in the medical management of ALS.

Authors:  Alisa Brownlee; Merisa Palovcak
Journal:  NeuroRehabilitation       Date:  2007       Impact factor: 2.138

4.  Service use and needs of people with motor neurone disease and their carers in Scotland.

Authors:  E R van Teijlingen; E Friend; A D Kamal
Journal:  Health Soc Care Community       Date:  2001-11

Review 5.  Motor neuron disease: classification and nomenclature.

Authors:  M Swash; J Desai
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-03

6.  Supported treadmill ambulation for amyotrophic lateral sclerosis: a pilot study.

Authors:  Mohammed Sanjak; Elena Bravver; William L Bockenek; H James Norton; Benjamin R Brooks
Journal:  Arch Phys Med Rehabil       Date:  2010-12       Impact factor: 3.966

7.  Social services homecare for people with motor neurone disease/amyotrophic lateral sclerosis: why are such services used or refused?

Authors:  Mary R O'Brien; Bridget Whitehead; Philip N Murphy; J Douglas Mitchell; Barbara A Jack
Journal:  Palliat Med       Date:  2011-03-07       Impact factor: 4.762

Review 8.  Primary lateral sclerosis, hereditary spastic paraplegia and amyotrophic lateral sclerosis: discrete entities or spectrum?

Authors:  Michael J Strong; Paul H Gordon
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2005-03

Review 9.  Multidisciplinary care for adults with amyotrophic lateral sclerosis or motor neuron disease.

Authors:  Louisa Ng; Fary Khan; Susan Mathers
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

10.  The provision of assistive devices and home adaptations to patients with ALS in the Netherlands: patients' perspectives.

Authors:  Huub Creemers; Anita Beelen; Hepke Grupstra; Frans Nollet; Leonard H van den Berg
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-06-05       Impact factor: 4.092

View more
  2 in total

1.  Transition from in-hospital ventilation to home ventilation: process description and quality indicators.

Authors:  Marc Kastrup; Benjamin Tittmann; Tanja Sawatzki; Martin Gersch; Charlotte Vogt; Max Rosenthal; Simone Rosseau; Claudia Spies
Journal:  Ger Med Sci       Date:  2017-12-19

2.  "Back into Life-With a Power Wheelchair": Learning from People with Severe Stroke through a Participatory Photovoice Study in a Metropolitan Area in Germany.

Authors:  Tabea Böttger; Silke Dennhardt; Julia Knape; Ulrike Marotzki
Journal:  Int J Environ Res Public Health       Date:  2022-08-23       Impact factor: 4.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.